$BEATW

HeartBeam, Inc.

CIK:0001779372|SEC Filings

Condensed Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Operating Expenses:
Selling, general and administrative	$ 2,764	$ 1,711	$ 5,110	$ 3,720
Research and development	2,328	3,326	4,698	6,818
Total operating expenses	5,092	5,037	9,808	10,538
Loss from operations	(5,092)	(5,037)	(9,808)	(10,538)
Other Income and (Expense)
Interest income	53	63	69	80
Total other income	53	63	69	80
Loss before provision for income taxes	(5,039)	(4,974)	(9,739)	(10,458)
Income tax provision	0	0	0	0
Net Loss	$ (5,039)	$ (4,974)	$ (9,739)	$ (10,458)
Net loss per share, basic (in dollars per share)	$ (0.1)	$ (0.15)	$ (0.21)	$ (0.32)
Net loss per share, diluted (in dollars per share)	$ (0.1)	$ (0.15)	$ (0.21)	$ (0.32)
Weighted average common shares outstanding, basic (in shares)	52,774,898	33,834,950	46,715,063	32,184,025
Weighted average common shares outstanding, diluted (in shares)	52,774,898	33,834,950	46,715,063	32,184,025

Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash Flows From Operating Activities
Net Income (Loss)	$ (9,739,000)	$ (10,458,000)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	81,000	15,000
Stock based compensation expense	2,918,000	2,286,000
Stock issuance upon vesting of restricted stock units	505,000	0
Stock issuance for services	100,000	0
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	38,000	85,000
Inventory	(7,000)	0
Accounts payable and accrued expenses	(848,000)	150,000
Net cash used in operating activities	(6,952,000)	(7,922,000)
Cash Flows From Investing Activities
Purchase of property and equipment	(495,000)	(102,000)
Purchase of short-term investments	0	(3,760,000)
Maturities of short-term investments	0	1,963,000
Net cash used in investing activities	(495,000)	(1,899,000)
Cash Flows From Financing Activities
Proceeds from exercise of stock options	10,000	0
Net cash provided by financing activities	11,790,000	10,700,000
Net increase in cash and restricted cash	4,343,000	879,000
Cash, cash equivalents and restricted cash – Beginning of period	4,436,000	2,433,000
Cash, cash equivalents and restricted cash – Ending of period	8,779,000	3,312,000
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	8,722,000	3,256,000
Restricted cash (included in other assets)	57,000	56,000
Total cash, cash equivalents and restricted cash	8,779,000	3,312,000
Supplemental Disclosures of Cash Flow Information:
Purchase of property and equipment in accounts payable	68,000	27,000
Taxes paid	0	0
Public Stock Offering
Cash Flows From Financing Activities
Proceeds from sale of equity, net of issuance costs	10,265,000	10,250,000
At The Market Offering
Cash Flows From Financing Activities
Proceeds from sale of equity, net of issuance costs	$ 1,515,000	$ 450,000

Condensed Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current Assets:
Cash and cash equivalents	$ 8,722	$ 4,380
Prepaid expenses and other current assets	164	202
Inventory	110	103
Total Current Assets	8,996	4,685
Property and equipment, net	1,584	1,102
Other assets	57	56
Total Assets	10,637	5,843
Current Liabilities:
Accounts payable (includes related party $0 and $5, respectively)	608	1,053
Accrued expenses (includes related party $5 and $0, respectively)	1,852	2,187
Total Current Liabilities	2,460	3,240
Total Liabilities	2,460	3,240
Commitments and Contingencies (Note 8)
Stockholders’ Equity
Preferred stock - $0.0001 par value; 10,000,000 authorized; 0 shares outstanding at June 30, 2026 and December 31, 2025	0	0
Common stock - $0.0001 par value 100,000,000 shares authorized; 56,349,171 and 40,117,404 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively	6	4
Additional paid in capital	95,198	79,887
Accumulated deficit	(87,027)	(77,288)
Total Stockholders’ Equity	8,177	2,603
Total Liabilities and Stockholders' Equity	$ 10,637	$ 5,843